☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Upfront Payment
uniQure to Acquire Corlieve Therapeutics for $55M
June 23, 2021
Roche Licenses Halozyme's ENHANZE Technology for ~$190M for the Development of Therapeutic Targets
October 31, 2018
Load more...
Back to Home
